South Korean Won Will Appreciate In 2024
Country Risk / South Korea / Fri 01 Mar, 2024
2023 | Spot | 2024f | 2025f | |
---|---|---|---|---|
KRW/USD, avg | 1,306 | 1,332 | 1,260 | 1,215 |
KRW/EUR, avg | 1,412 | 1,445 | 1,360 | 1,336 |
Policy Rate, % eop | 3.50 | 3.50 | 2.50 | 2.00 |
Key View
Country Risk / South Korea / Fri 01 Mar, 2024
2023 | Spot | 2024f | 2025f | |
---|---|---|---|---|
KRW/USD, avg | 1,306 | 1,332 | 1,260 | 1,215 |
KRW/EUR, avg | 1,412 | 1,445 | 1,360 | 1,336 |
Policy Rate, % eop | 3.50 | 3.50 | 2.50 | 2.00 |
Key View
Country Risk / Portugal / Fri 01 Mar, 2024
Key View
Country Risk / Turkey / Thu 29 Feb, 2024
Key View
Country Risk / Tanzania / Thu 29 Feb, 2024
Key View
Country Risk / Congo, Dem. Rep. / Thu 29 Feb, 2024
Key View
Country Risk / Russia / Thu 29 Feb, 2024
Key View
Country Risk / Germany / Thu 29 Feb, 2024
Key View
Pharmaceuticals / India / Thu 29 Feb, 2024
The Latest: On February 26 2024, Pfizer took a significant step to foster innovation in India's burgeoning startup ecosystem, particularly in the healthcare sector. The drugmaker unveiled a strategic partnership with the National Institute of Pharmaceutical Education & Research (NIPER) in Ahmedabad, India. This alliance is focused on empowering
Country Risk / Argentina / Wed 28 Feb, 2024
Key View
Country Risk / Nigeria / Wed 28 Feb, 2024
Key View